However, a recent study suggested that it underestimates the prognosis in patients with MPE caused by lung adenocarcinoma.20 The recently published PROMISE score system21 includes a clinical score method and a biological score method, which is a clinical score plus tissue inhibitor of metalloproteinases 1 (TIMP1). This evidence concerns the gene TIMP1 and lung adenocarcinoma.